A Multi-Center, Open-Labeled, Intervention Study: The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Ziprasidone (Primary)
- Indications Bipolar disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 21 Oct 2016 New trial record